# Effect of Addition of Mannitol to Bupivacaine on IANB Success and Post-endodontic Pain

> **NCT03749408** · PHASE2,PHASE3 · COMPLETED · sponsor: **Cairo University** · enrollment: 60 (actual)

## Conditions studied

- Irreversible Pulpitis

## Interventions

- **DRUG:** bupivacaine plus mannitol
- **DRUG:** bupivacaine alone

## Key facts

- **NCT ID:** NCT03749408
- **Lead sponsor:** Cairo University
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-12
- **Primary completion:** 2014-06
- **Final completion:** 2014-06
- **Target enrollment:** 60 (ACTUAL)
- **Last updated:** 2018-11-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03749408

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03749408, "Effect of Addition of Mannitol to Bupivacaine on IANB Success and Post-endodontic Pain". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03749408. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*